Search results
Results from the WOW.Com Content Network
Management of the dawn phenomenon varies by patient and thus should be done with regular assistance from a patient's physician. Some treatment options include, but are not limited to, dietary modifications, increased exercise before breakfast and during the evening, and oral anti-hyperglycemic medications if a patient's HbA1c is > 7%.
Sundowning, or sundown syndrome, [1] is a neurological phenomenon wherein people with delirium or some form of dementia experience increased confusion and restlessness beginning in the late afternoon and early evening. It is most commonly associated with Alzheimer's disease but is also found in those
Dementia of the Alzheimer's type, with late onset, with delusions: Included only in the DSM-IV. 290.21: Dementia of the Alzheimer's Type, With late onset, with depressed mood: Included only in the DSM-IV. 294.10: Dementia of the Alzheimer's Type, with late onset, without behavioral disturbance: Included only in the DSM-IV-TR. 301.6: Dependent ...
294.1x Dementia due to Huntington's disease (coded 294.1 in the DSM-IV) 294.1x Dementia due to Pick's disease (coded 290.10 in the DSM-IV) 294.1x Dementia due to Creutzfeldt–Jakob disease (coded 290.10 in the DSM-IV) 294.1x Dementia due to ... [Indicate the general medical condition not listed above] (coded 294.1 in the DSM-IV) 294.8 Dementia NOS
Dementia directly affects more than 55 million people worldwide, and up to 70% of those people have Alzheimer’s disease, which is characterized by a loss of brain cells associated with the toxic ...
Dementia with Lewy bodies (DLB) is a type of dementia, a group of diseases involving progressive neurodegeneration of the central nervous system. [11] It is one of the two Lewy body dementias, along with Parkinson's disease dementia. [12] Dementia with Lewy bodies can be classified in other ways.
The authors also cautioned that the findings cannot be applied to people without diabetes. MARKET REACTION U.S.-listed shares of Novo Nordisk rose 1.8%, while shares of rival Eli Lilly rose 1.6%.
Some drugs used to treat type 2 diabetes could also help lower a person’s risk of neurodegenerative diseases, such as Alzheimer’s. Image credit: martin-dm/Getty Images.